Leukemia
A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in Participants With Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011) (MK-1026-011)
- Details
ClinicalTrials.gov ID:
NCT06136559
Diagnosis Type:
NA
USOR Number:
- Address
,
P: